Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Common Equity (2019 - 2025)

IM Cannabis has reported Common Equity over the past 7 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Common Equity at -$2.7 million for Q4 2025, down 171.27% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (down 171.27% YoY), and the annual figure for FY2025 was -$2.7 million, down 169.71%.
  • Common Equity for Q4 2025 was -$2.7 million at IM Cannabis, down from $3.8 million in the prior quarter.
  • Over the last five years, Common Equity for IMCC hit a ceiling of $159.6 million in Q4 2021 and a floor of -$2.7 million in Q4 2025.
  • Median Common Equity over the past 5 years was $10.6 million (2023), compared with a mean of $37.6 million.
  • Biggest five-year swings in Common Equity: soared 1775.56% in 2021 and later tumbled 171.27% in 2025.
  • IM Cannabis' Common Equity stood at $159.6 million in 2021, then plummeted by 89.55% to $16.7 million in 2022, then plummeted by 36.31% to $10.6 million in 2023, then crashed by 64.69% to $3.8 million in 2024, then tumbled by 171.27% to -$2.7 million in 2025.
  • The last three reported values for Common Equity were -$2.7 million (Q4 2025), $3.8 million (Q4 2024), and $10.6 million (Q4 2023) per Business Quant data.